Last $8.51 USD
Change Today +0.28 / 3.40%
Volume 161.6K
ICAD On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

icad inc (ICAD) Snapshot

Open
$8.20
Previous Close
$8.23
Day High
$8.75
Day Low
$8.11
52 Week High
01/16/14 - $14.11
52 Week Low
04/24/13 - $4.24
Market Cap
117.2M
Average Volume 10 Days
131.6K
EPS TTM
$-0.54
Shares Outstanding
13.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ICAD INC (ICAD)

Related News

No related news articles were found.

icad inc (ICAD) Related Businessweek News

No Related Businessweek News Found

icad inc (ICAD) Details

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. The company operates in two segments, Cancer Detection and Cancer Therapy. It offers electronic brachytherapy products (eBx), including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, and non-melanoma skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated, including intraoperative radiation therapy. The company also provides digital and magnetic resonance imaging (MRI) computer-aided detection (CAD) products, such as SecondLook systems that detect and identify suspicious masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer’s network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to picture archiving and communication system and/or review workstations. In addition, it offers advanced image analysis and workflow solutions in MRI imaging; and advanced image analysis and workflow solutions in computed tomography (CT) colonography, including VeraLook that supports the detection of colonic polyps in conjunction with CT colonography. Further, the company provides film based products, such as TotalLook MammoAdvantage system, which is a second generation mammography specific digitizer that converts prior mammography films to digital images. iCAD, Inc. primarily serves hospitals, ambulatory care centers and free standing radiation oncology facilities, and other office-based uses. The company sells its products directly, as well as through various original equipment manufacturer partners, distributors, and resellers worldwide. It has strategic partnership agreement with Invivo Corporation. The company was founded in 1984 and is headquartered in Nashua, New Hampshire.

102 Employees
Last Reported Date: 03/3/14
Founded in 1984

icad inc (ICAD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $412.4K
Chief Operating Officer, Chief Financial Offi...
Total Annual Compensation: $328.6K
Senior Vice President of Marketing and Strate...
Total Annual Compensation: $253.6K
Compensation as of Fiscal Year 2013.

icad inc (ICAD) Key Developments

iCAD, Inc. Treats 1,000 Early Stage Breast Cancer Patients with Intraoperative Radiation Therapy Using the Xoft System

iCAD, Inc. announced at the 31(st) Annual Miami Breast Cancer Conference that more than 1,000 early stage breast cancer patients have been treated with Intraoperative Radiation Therapy (IORT) using the Xoft(R) Axxent(R) Electronic Brachytherapy System(R). With IORT, a full course of radiation therapy is delivered to the patient in the operating room immediately following lumpectomy, replacing six to eight weeks of daily traditional radiation.

iCAD, Inc. Presents at RBC Capital Markets 2014 Global Healthcare Conference, Feb-25-2014 10:00 AM

iCAD, Inc. Presents at RBC Capital Markets 2014 Global Healthcare Conference, Feb-25-2014 10:00 AM. Venue: New York Palace Hotel, New York, New York, United States. Speakers: Kenneth M. Ferry, Chief Executive Officer, President and Director.

iCAD, Inc. Appoints Robert L. Goodman as Director

On February 14, 2014, iCAD, Inc. increased the size of its Board of Directors to nine people. Following the increase in the size of the Board, the Board appointed Dr. Robert L. Goodman to fill the vacancy created by such increase. There are no arrangements or understandings between Dr. Goodman and any other persons pursuant to which Dr. Goodman was appointed a director of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICAD:US $8.51 USD +0.28

ICAD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $20.79 USD -0.25
Intraop Medical Corp $0.03 USD +0.005
Merge Healthcare Inc $2.43 USD +0.01
View Industry Companies
 

Industry Analysis

ICAD

Industry Average

Valuation ICAD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.8x
Price/Book 4.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICAD INC, please visit www.icadmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.